Shares of U.S. based cannabis operator Curaleaf (CURLF) are up 7% in late afternoon trading on Monday after reporting that NJ’s CRC Board reverses, and fully approves adult use renewals. Curaleaf Holdings announced that Monday, April 17th, the Board of the New Jersey Cannabis Regulatory CRC reversed itself and voted to approve Curaleaf’s adult use cannabis licenses. The CRC Board’s decision came after first voting to vacate their decision from Thursday, April 13th, when they attempted to deny Curaleaf’s adult use license renewals. Said Curaleaf CEO Matt Darin, "Today’s decision by the CRC Board to vacate their unprecedented action last week is an incredible victory for our 500 NJ team members and vindication for what we knew all along," the company said in a statement. Other publicly traded companies in the cannabis space include: Akerna (KERN), Acreage Holdings (ACRHF), Aleafia (ALEAF), Atai Life Sciences (ATAI), Audacious (AUSAF), Aurora Cannabis (ACB), Awakn Life Sciences (AWKNF), Ayr Wellness (AYRWF), Canopy Growth (CGC).
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CURLF:
- Curaleaf says working with New Jersey to ensure license renewal
- Curaleaf price target lowered to $8 from $11 at Alliance Global Partners
- NJ cannabis vote ‘crushing blow’ for Curaleaf, says Wedbush
- Curaleaf license not renewed by NJ regulators, NJ.com reports
- Curaleaf Completes Acquisition of Deseret Wellness
